Elon Musk, Bernie Sanders and Others Miss the Mark Over Pricey Insulin Posted on November 21, 2022 by Bodinz Markets Heard on the Street Big Pharma has taken much of the heat for sky-high insulin prices, but scrutiny could soon shift to other companies grabbing a growing slice of spending Source link
Stock news SEC Set to Propose Rules That Would Squeeze Stock-Market Middlemen Bodinz December 14, 2022 Markets Financial Regulation Agency considers biggest overhaul of stock-market structure since mid-2000s Source link
Stock news AIG to Officially Shut Unit That Failed in Financial Crisis Bodinz December 14, 2022 Markets Finance Financial Products unit filing for bankruptcy in step toward final shutdown Source link
Stock news What Fed Interest Rate Increases Mean for Your 2023 Financial Plans Bodinz December 14, 2022 After a year of rising interest rates, higher prices and volatile markets, financial advisers say […]